Ekso Bionics Holdings Statistics

Total Valuation

LON:0IFR has a market cap or net worth of GBP 6.95 million. The enterprise value is 6.56 million.

Market Cap	6.95M
Enterprise Value	6.56M

Important Dates

The next estimated earnings date is Monday, April 28, 2025.

Earnings Date	Apr 28, 2025
Ex-Dividend Date	n/a

Share Statistics

Current Share Class	n/a
Shares Outstanding	n/a
Shares Change (YoY)	+45.39%
Shares Change (QoQ)	+21.32%
Owned by Insiders (%)	n/a
Owned by Institutions (%)	n/a
Float	21.11M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	n/a
PB Ratio	n/a
P/TBV Ratio	1.13
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

EV / Earnings	-0.72
EV / Sales	0.48
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	-0.83

Financial Position

The company has a current ratio of 2.50, with a Debt / Equity ratio of 0.47.

Current Ratio	2.50
Quick Ratio	1.82
Debt / Equity	0.47
Debt / EBITDA	n/a
Debt / FCF	-0.61
Interest Coverage	-38.88

Financial Efficiency

Return on equity (ROE) is -89.52% and return on invested capital (ROIC) is -33.99%.

Return on Equity (ROE)	-89.52%
Return on Assets (ROA)	-23.53%
Return on Invested Capital (ROIC)	-33.99%
Return on Capital Employed (ROCE)	-54.72%
Revenue Per Employee	223,718
Profits Per Employee	-141,407
Employee Count	66
Asset Turnover	0.65
Inventory Turnover	1.75

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -71.89% in the last 52 weeks. The beta is 1.88, so LON:0IFR's price volatility has been higher than the market average.

Beta (5Y)	1.88
52-Week Price Change	-71.89%
50-Day Moving Average	0.55
200-Day Moving Average	1.17
Relative Strength Index (RSI)	31.59
Average Volume (20 Days)	2,652

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	2.14

Income Statement

In the last 12 months, LON:0IFR had revenue of GBP 14.32 million and -9.05 million in losses. Loss per share was -0.45.

Revenue	14.32M
Gross Profit	7.60M
Operating Income	-8.36M
Pretax Income	-9.05M
Net Income	-9.05M
EBITDA	-7.07M
EBIT	-8.36M
Loss Per Share	-0.45

Full Income Statement

Balance Sheet

The company has 5.19 million in cash and 4.78 million in debt, giving a net cash position of 407,373.

Cash & Cash Equivalents	5.19M
Total Debt	4.78M
Net Cash	407,373
Net Cash Per Share	n/a
Equity (Book Value)	10.15M
Book Value Per Share	0.46
Working Capital	9.03M

Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was -7.86 million and capital expenditures -29,554, giving a free cash flow of -7.89 million.

Operating Cash Flow	-7.86M
Capital Expenditures	-29,554
Free Cash Flow	-7.89M
FCF Per Share	n/a

Full Cash Flow Statement

Margins

Gross margin is 53.06%, with operating and profit margins of -58.35% and -63.21%.

Gross Margin	53.06%
Operating Margin	-58.35%
Pretax Margin	-63.21%
Profit Margin	-63.21%
EBITDA Margin	-49.38%
EBIT Margin	-58.35%
FCF Margin	n/a

Dividends & Yields

LON:0IFR does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-45.39%
Shareholder Yield	-45.39%
Earnings Yield	-130.19%
FCF Yield	-113.57%

Stock Splits

The last stock split was on March 25, 2020. It was a reverse split with a ratio of 0.0666666667.

Last Split Date	Mar 25, 2020
Split Type	Reverse
Split Ratio	0.0666666667

Scores

LON:0IFR has an Altman Z-Score of -12.24. A Z-score under 3 suggests an increased risk of bankruptcy.

Altman Z-Score	-12.24
Piotroski F-Score	n/a